Macrolide antibiotics induce apoptosis of human peripheral lymphocytes in vitro

被引:28
作者
Ishimatsu, Y
Kadota, J
Iwashita, T
Nagata, T
Ishii, H
Shikuwa, C
Kaida, H
Mukae, H
Kohno, S
机构
[1] Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 8528501, Japan
[2] Oita Univ, Fac Med, Div Pathogenesis & Dis Control, Dept Infect Dis, Oita 87011, Japan
关键词
macrolide antibiotics; lymphocyte; apoptosis; Fas; Fas-ligand;
D O I
10.1016/j.ijantimicag.2004.03.022
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We previously reported that long-term administration of macrolides (MCL) reduced the number of lymphocytes in bronchoalveolar lavage fluid (BALF) of patients with chronic lower respiratory tract disease. To investigate the anti-inflammatory activity of macrolides, we evaluated their effect on apoptosis of lymphocytes isolated from human peripheral blood. Lymphocytes treated with clarithromycin, azithromycin and josamycin at a final concentration of 200 mug/ml showed positive staining for Annexin V, Fas and Fas ligand using flow cytometry with time at 12-72 h, while other antibiotics did not. Our results suggest that macrolides induce apoptosis of lymphocytes through Fas-Fas ligand pathway and could potentially reduce the number of lymphocytes in the lungs of patients with chronic lower respiratory tract disease. (C) 2004 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:247 / 253
页数:7
相关论文
共 27 条
  • [1] ERYTHROMYCIN SHORTENS NEUTROPHIL SURVIVAL BY ACCELERATING APOPTOSIS
    AOSHIBA, K
    NAGAI, A
    KONNO, K
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (04) : 872 - 877
  • [2] Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis
    Boirivant, M
    Pica, R
    DeMaria, R
    Testi, R
    Pallone, F
    Strober, W
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (11) : 2616 - 2622
  • [3] Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects
    Conte, JE
    Golden, J
    Duncan, S
    McKenna, E
    Lin, E
    Zurlinden, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) : 1617 - 1622
  • [4] INTRAPULMONARY PHARMACOKINETICS OF CLARITHROMYCIN AND OF ERYTHROMYCIN
    CONTE, JE
    GOLDEN, JA
    DUNCAN, S
    MCKENNA, E
    ZURLINDEN, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) : 334 - 338
  • [5] Inhibitory effect of erythromycin on interleukin 8 production by 1 alpha,25-dihydroxyvitamin D3-stimulated THP-1 cells
    Fujii, T
    Kadota, JI
    Morikawa, T
    Matsubara, Y
    Kawakami, K
    Iida, K
    Shirai, R
    Taniguchi, H
    Kaseda, M
    Kawamoto, S
    Kohno, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (06) : 1548 - 1551
  • [6] ERYTHROMYCIN INHIBITS RESPIRATORY GLYCOCONJUGATE SECRETION FROM HUMAN AIRWAYS INVITRO
    GOSWAMI, SK
    KIVITY, S
    MAROM, Z
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (01): : 72 - 78
  • [7] PENETRATION OF MACROLIDES INTO HUMAN POLYMORPHONUCLEAR LEUKOCYTES
    ISHIGURO, M
    KOGA, H
    KOHNO, S
    HAYASHI, T
    YAMAGUCHI, K
    HIROTA, M
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 (05) : 719 - 729
  • [8] GASTROINTESTINAL MOTOR-STIMULATING ACTIVITY OF MACROLIDE ANTIBIOTICS AND ANALYSIS OF THEIR SIDE-EFFECTS ON THE CANINE GUT
    ITOH, Z
    SUZUKI, T
    NAKAYA, M
    INOUE, M
    MITSUHASHI, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (06) : 863 - 869
  • [9] A MECHANISM OF ERYTHROMYCIN TREATMENT IN PATIENTS WITH DIFFUSE PANBRONCHIOLITIS
    KADOTA, J
    SAKITO, O
    KOHNO, S
    SAWA, H
    MUKAE, H
    ODA, H
    KAWAKAMI, K
    FUKUSHIMA, K
    HIRATANI, K
    HARA, K
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (01): : 153 - 159
  • [10] Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis; The importance of cytotoxic T cells
    Kawakami, K
    Kadota, J
    Iida, K
    Fujii, T
    Shirai, R
    Matsubara, Y
    Kohno, S
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 (02) : 410 - 416